Therapeutic strategies for liver diseases based on redox control systems

被引:12
|
作者
Lee, Jooyoung [1 ]
Kim, Jiye [1 ]
Lee, Ryunjin [1 ]
Lee, Eunkyeong [1 ]
Choi, Tae Gyu [2 ,3 ]
Lee, Amy Sinyoung [4 ]
Yoon, Young-In [5 ]
Park, Gil-Chun [5 ]
Namgoong, Jung-Man [6 ]
Lee, Sung-Gyu [5 ]
Tak, Eunyoung [1 ]
机构
[1] Univ Ulsan, Asan Med Inst Convergence Sci & Technol, Coll Med, Asan Med Ctr,Dept Convergence Med, Seoul 05505, South Korea
[2] Kyung Hee Univ, Sch Med, Dept Biochem & Mol Biol, Seoul 02447, South Korea
[3] Kyung Hee Univ, Biomed Sci Inst, Seoul 02447, South Korea
[4] Asan Med Ctr, Asan Inst Life Sci, Seoul 02477, South Korea
[5] Univ Ulsan, Asan Med Ctr, Coll Med, Div Hepatobiliary Surg & Liver Transplanta,Dept Su, Seoul 05505, South Korea
[6] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pediat Surg, Seoul 05505, South Korea
基金
新加坡国家研究基金会;
关键词
Reactive oxygen species; Redox control system; Liver disease; Therapeutic target; NF-KAPPA-B; MITOCHONDRIAL PERMEABILITY TRANSITION; OXYGEN SPECIES PRODUCTION; ALCOHOLIC FATTY LIVER; REACTIVE OXYGEN; OXIDATIVE STRESS; GROWTH-FACTOR; SUPEROXIDE DISMUTASES; MOLECULAR-MECHANISMS; REGULATORY ELEMENT;
D O I
10.1016/j.biopha.2022.113764
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
In the liver, reactive oxygen species (ROS) are constantly released during cellular metabolic processes, and excess ROS production can cause redox stress. The redox stress is both beneficial for and harmful to the survival of cells since it modulates the cellular redox control system. The redox control system is a series of cellular responses that are responsible for maintaining a balanced oxidation-reduction status. Many cellular processes including growth, proliferation, and senescence are sensitively regulated by the redox control system. Imbalance of redox induces redox stress and damages DNA, proteins, and lipids in cells, and further contributes to the pathogenesis of severe diseases and disorders like cancer. However, the cellular redox control system also utilizes redox stress -responsive pathways and increases antioxidant enzymes to aid cell survival. Therefore, a deeper understand-ing of the connection between the redox control system and liver disease is likely to pave the way for the future development of new therapeutic strategies. This review will examine the redox control systems in liver with responsive regulating molecules, current knowledge of the redox control system and liver disease, and suggest potential therapeutic targets for liver diseases.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Nonalcoholic fatty liver disease: molecular pathways and therapeutic strategies
    Huang, Yue Ye
    Gusdon, Aaron M.
    Qu, Shen
    LIPIDS IN HEALTH AND DISEASE, 2013, 12
  • [32] Redox Unbalance: NADPH Oxidase as Therapeutic Target in Blood Pressure Control
    Rabelo, Luiza A.
    de Souza, Valeria Nunes
    Sa da Fonseca, Lucas Jose
    Sampaio, Walkyria O.
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2010, 94 (05) : 684 - 693
  • [33] Thiol-based redox-active proteins as cardioprotective therapeutic agents in cardiovascular diseases
    Andreadou, Ioanna
    Efentakis, Panagiotis
    Frenis, Katie
    Daiber, Andreas
    Schulz, Rainer
    BASIC RESEARCH IN CARDIOLOGY, 2021, 116 (01)
  • [34] Oxidative Stress and Redox Signaling in the Pathophysiology of Liver Diseases
    Mooli, Raja Gopal Reddy
    Mukhi, Dhanunjay
    Ramakrishnan, Sadeesh K.
    COMPREHENSIVE PHYSIOLOGY, 2022, 12 (02) : 3167 - 3192
  • [35] Self-therapeutic metal-based nanoparticles for treating inflammatory diseases
    Han, Ruifang
    Xiao, Yu
    Bai, Qianqian
    Choi, Chung Hang Jonathan
    ACTA PHARMACEUTICA SINICA B, 2023, 13 (05) : 1847 - 1865
  • [36] Dual role of pyroptosis in liver diseases: mechanisms, implications, and therapeutic perspectives
    Yang, Siyuan
    Zou, Yunyi
    Zhong, Chunhua
    Zhou, Zuoqiong
    Peng, Xiyang
    Tang, Changfa
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2025, 13
  • [37] The role of redox-mediated lysosomal dysfunction and therapeutic strategies
    He, Xiaomeng
    Li, Xuening
    Tian, Wei
    Li, Chenyu
    Li, Pengfei
    Zhao, Jingyuan
    Yang, Shilei
    Li, Shuai
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 165
  • [38] Revisiting therapeutic strategies for ovarian cancer by focusing on redox homeostasis
    Kobayashi, Hiroshi
    Imanaka, Shogo
    Shigetomi, Hiroshi
    ONCOLOGY LETTERS, 2022, 23 (03)
  • [39] Therapeutic potential of oleanolic acid in liver diseases
    Wang, Yongxin
    Liu, Kai
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 (07) : 4537 - 4554
  • [40] Therapeutic potential of phages in autoimmune liver diseases
    Gorski, A.
    Jonczyk-Matysiak, E.
    Lusiak-Szelachowska, M.
    Weber-Dabrowska, B.
    Miedzybrodzki, R.
    Borysowski, J.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2018, 192 (01) : 1 - 6